Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bombesin BB2 Receptor (BB2R), also known as the gastrin-releasing peptide receptor (GRPR), is a G protein-coupled receptor that binds to gastrin-releasing peptide (GRP). It plays diverse roles in the gastrointestinal system, central nervous system, and other tissues. BB2R is overexpressed in several human tumors, making it a potential target for diagnostic imaging and targeted therapy.
Gq/11 protein activation, leading to phospholipase C activation and increased intracellular calcium; Inhibition of mitogenic effects via antagonists.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bombesin BB2 Receptor (BB2R).